HMGCR and familial dilated cardiomyopathy: Current therapeutic strategies for DCM involve insulin and insulin-secreting agents, oral antihyperglycemic medication, β-blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, calciumion channel antagonists, and hydroxymethylglutaryl CoA reductase inhibitors.